Healthcare provider profile · identity verified

Lee Austin Fredrickson, M.D.

Internal Medicine · SALEM, OH · NPI 1427476753

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	486	138
Levothyroxine Sodium	Levothyroxine Sodium	360	93
Amlodipine Besylate	Amlodipine Besylate	289	80
Lisinopril	Lisinopril	279	68
Losartan Potassium	Losartan Potassium	251	79
Metoprolol Succinate	Metoprolol Succinate	246	73
Omeprazole	Omeprazole	241	76
Rosuvastatin Calcium	Rosuvastatin Calcium	201	60
Simvastatin	Simvastatin	166	46
Sertraline Hcl	Sertraline Hcl	157	49
Metoprolol Tartrate	Metoprolol Tartrate	155	40
Metformin Hcl	Metformin Hcl	146	41
Eliquis	Apixaban	127	35
Potassium Chloride	Potassium Chloride	122	42
Furosemide	Furosemide	115	45
Metformin Hcl Er	Metformin Hcl	113	30
Pantoprazole Sodium	Pantoprazole Sodium	113	38
Fluticasone Propionate	Fluticasone Propionate	105	40
Prednisone	Prednisone	103	55
Tamsulosin Hcl	Tamsulosin Hcl	100	36
Duloxetine Hcl	Duloxetine Hcl	95	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	92	24
Gabapentin	Gabapentin	88	27
Allopurinol	Allopurinol	86	22
Hydrochlorothiazide	Hydrochlorothiazide	85	24
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	80	66
Pravastatin Sodium	Pravastatin Sodium	80	25
Glipizide Er	Glipizide	78	21
Xarelto	Rivaroxaban	75	17
Ozempic	Semaglutide	72	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	68	16
Carvedilol	Carvedilol	67	16
Pioglitazone Hcl	Pioglitazone Hcl	66	19
Montelukast Sodium	Montelukast Sodium	65	20
Warfarin Sodium	Warfarin Sodium	65	14
Spironolactone	Spironolactone	64	20
Trazodone Hcl	Trazodone Hcl	63	21
Jardiance	Empagliflozin	55	13
Clopidogrel	Clopidogrel Bisulfate	53	15
Synthroid	Levothyroxine Sodium	53	14
Azithromycin	Azithromycin	52	49
Famotidine	Famotidine	52	17
Albuterol Sulfate Hfa	Albuterol Sulfate	50	19
Citalopram Hbr	Citalopram Hydrobromide	50	15
Donepezil Hcl	Donepezil Hcl	49	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	45	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	44	37
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	43	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	suppressed
Mirtazapine	Mirtazapine	42	18
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Enalapril Maleate	Enalapril Maleate	35	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Atenolol	Atenolol	34	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	24
Tresiba Flextouch U-100	Insulin Degludec	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	31	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	12
Bupropion Xl	Bupropion Hcl	29	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Naproxen	Naproxen	28	18
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	16
Bumetanide	Bumetanide	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	15
Primidone	Primidone	26	suppressed
Entresto	Sacubitril/Valsartan	25	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Finasteride	Finasteride	23	suppressed
Glipizide	Glipizide	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Digoxin	Digoxin	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Methylprednisolone	Methylprednisolone	20	19
Mounjaro	Tirzepatide	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Cephalexin	Cephalexin	17	12
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Pen Needle	Pen Needle, Diabetic	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Amoxicillin	Amoxicillin	16	13
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Colchicine	Colchicine	15	13
Repatha Sureclick	Evolocumab	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Valsartan	Valsartan	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	14
Dilt-Xr	Diltiazem Hcl	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Nystatin	Nystatin	12	suppressed
Perphenazine-Amitriptyline	Perphenazine/Amitriptyline Hcl	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error